IRIDEX Corporation (IRIX)
NASDAQ: IRIX · Real-Time Price · USD
0.9403
+0.0109 (1.17%)
Dec 5, 2025, 4:00 PM EST - Market closed
IRIDEX Employees
IRIDEX had 93 employees as of December 28, 2024. The number of employees decreased by 18 or -16.22% compared to the previous year.
Employees
93
Change (1Y)
-18
Growth (1Y)
-16.22%
Revenue / Employee
$544,591
Profits / Employee
-$54,699
Market Cap
16.16M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IRIX News
- 2 days ago - Iridex to Present at the Sidoti Year-End Virtual Investor Conference - GlobeNewsWire
- 25 days ago - IRIDEX Corporation (IRIX) Q3 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
- 25 days ago - Iridex Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025 - GlobeNewsWire
- 3 months ago - Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance - GlobeNewsWire
- 4 months ago - IRIDEX Corporation (IRIX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Iridex Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema - GlobeNewsWire